Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 14, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 14, Issue 11 (2005)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 14, Issue 11 (2005)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Volume 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Article

Therapeutic applications of carbon monoxide-releasing molecules

Roberto Motterlini, Brian E Mann & Roberta Foresti

Pages: 1305-1318

Published online: 28 Oct 2005

AbstractforTherapeutic applications of carbon monoxide-releasing molecules | References | PDF (197 KB)

714 Views
247 CrossRef citations
0Altmetric

Article

Endothelial function and its assessment

Dirk C Felmeden & Gregory YH Lip

Pages: 1319-1336

Published online: 28 Oct 2005

AbstractforEndothelial function and its assessment | References | PDF (193.8 KB)

142 Views
26 CrossRef citations
0Altmetric

Article

Clinical status of agents being developed for leishmaniasis

Jonathan Berman

Pages: 1337-1346

Published online: 28 Oct 2005

AbstractforClinical status of agents being developed for leishmaniasis | References | PDF (109.4 KB)

70 Views
43 CrossRef citations
0Altmetric

Article

Nitric oxide-modulating agents for gastrointestinal disorders

Brendan JR Whittle

Pages: 1347-1358

Published online: 28 Oct 2005

AbstractforNitric oxide-modulating agents for gastrointestinal disorders | References | PDF (132.9 KB)

65 Views
17 CrossRef citations
0Altmetric

Article

Benign prostatic hyperplasia: an insight into current investigational medical therapies

Atul Tiwari, N S Krishna, Kamna Nanda & Anita Chugh

Pages: 1359-1372

Published online: 28 Oct 2005

AbstractforBenign prostatic hyperplasia: an insight into current investigational medical therapies | References | PDF (191 KB)

137 Views
42 CrossRef citations
0Altmetric

Article

Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants

Guang-Yi Zhang & Quan-Guang Zhang

Pages: 1373-1383

Published online: 28 Oct 2005

AbstractforAgents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants | References | PDF (155.2 KB)

96 Views
35 CrossRef citations
0Altmetric

Article

Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease

Dirk Beher & Samuel L Graham

Pages: 1385-1409

Published online: 28 Oct 2005

AbstractforProtease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease | References | PDF (498 KB)

166 Views
50 CrossRef citations
0Altmetric

Article

Immunomodulatory drugs in multiple myeloma

Maurizio Zangari, Francesca Elice & Guido Tricot

Pages: 1411-1418

Published online: 28 Oct 2005

AbstractforImmunomodulatory drugs in multiple myeloma | References | PDF (109.8 KB)

154 Views
15 CrossRef citations
0Altmetric

Drug Evaluation

Article

Investigations on gossypol: past and present developments

Kalliopi Dodou

Pages: 1419-1434

Published online: 28 Oct 2005

AbstractforInvestigations on gossypol: past and present developments | References | PDF (182.3 KB)

309 Views
123 CrossRef citations
0Altmetric

Article

MC-1 (pyridoxal 5′-phosphate): novel therapeutic applications to reduce ischaemic injury

David E Kandzari, Jean-Pierre Dery, Paul W Armstrong, Deborah A Douglas, Marjorie E Zettler, G Karl-Gunnar Hidinger, Albert D Friesen & Robert A Harrington

Pages: 1435-1442

Published online: 28 Oct 2005

AbstractforMC-1 (pyridoxal 5′-phosphate): novel therapeutic applications to reduce ischaemic injury | References | PDF (138.3 KB)

65 Views
20 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation

AZUMA A, NUKIWA T, TSUBOI E et al.: Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. (2005) 171(9):1040-1047.

Sabina A Antoniu

Pages: 1443-1447

Published online: 28 Oct 2005

AbstractforPirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation | References | PDF (63.4 KB)

152 Views
6 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol

Amanda J. Hooper et al.

Editorial | Published online: 21 Jun 2024

Free Access

Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs

Lorenza Magagnoli et al.

Review Article | Published online: 19 Jun 2024

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development

Luca Iorio et al.

Report | Published online: 16 Jun 2024

Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

Ling Yang et al.

Article | Published online: 3 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.14, Iss.11, 2005)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?